Los Angeles, United States -- (SBWire) -- 10/13/2022 --Paclitaxel is a mitotic inhibitor used in Cancer chemotherapy; Paclitaxel was discovered in 1962 as a result of a U.S. National Cancer Institute-funded screening program; Monroe Wall and Mansukh Wani isolated the drug from the bark of the Pacific yew, Taxus brevifolia, and named it "taxol". North America and China are the largest producer of Paclitaxel , with a market share about 35% separately. Phyton, ScinoPharm, Huiang biopharma, Southpharma and Novasep are the top 5 manufacturers of industry, and they had more than 60% combined market share. Market Analysis and Insights: Global Paclitaxel Market The global Paclitaxel market size is projected to reach US$ 188.6 million by 2027, from US$ 107.1 million in 2020, at a CAGR of 8.2% during 2021-2027.
Request Sample Report and Full Report TOC:
https://www.qyresearch.com/sample-form/form/3268664/global-paclitaxel-market
The Essential Content Covered in the Global Paclitaxel Market Report :
* Top Key Company Profiles.
* Main Business and Rival Information
* SWOT Analysis and PESTEL Analysis
* Production, Sales, Revenue, Price and Gross Margin
* Market Share and Size
Top Players of Paclitaxel Market are Studied: Phyton, ScinoPharm, Novasep, Samyang, Polymed, TAPI (Teva), Fresenius-kabi, Huiang biopharma, Southpharma, Yunnan Hande, Hainan Yew Pharm, Jiangsu Yew Biotechnology
The report provides a 6-year forecast (2021-2027) assessed based on how the Paclitaxel market is predicted to grow in major regions like USA, Europe, Japan, China, India, Southeast Asia, South America, South Africa, Others.
Segmentation by Type: Natural Paclitaxel API, Semi-synthetic Paclitaxel API
Segmentation by Application: Ovarian Cancer, Cervical Cancer, Breast Cancer, Others
Reasons to Buy this Report:
Industry Size & Forecast: Estimations on the global Paclitaxel industry size on the basis of value and volume are provided in this part of the report
Study on Key Industry Trends: This section offers deep insights into the prevailing and upcoming Paclitaxel trends
Segmental Analysis: Here, the report has examined the high-growth segments including product type, application, and end-users, taking into account their CAGR, share, and size
Future Prospects: Current Paclitaxel developments and future opportunities estimated to emerge in the Paclitaxel industry are looked into in this portion of the study
Geography-wise Analysis: The authors of the report have studied the regions having growth potential to help companies plan their future investments
Study on Competitive Landscape: The industry experts have offered thorough information about the strategic tactics adopted by the industry participants to consolidate their position. This assessment will help the players to strategize their activities in future.
TO View Full Report: https://www.qyresearch.com/index/detail/3268664/Global-Paclitaxel-Market-Report-History-and-Forecast-2016-2027-Breakdown-Data-by-Manufacturers-Key-Regions-Types-and-Application
Global Paclitaxel Market Size to Surpass US$ 188.6 Million by 2027
Paclitaxel Market- This report is a compilation of a number of extensive,authentic research studies on the global Paclitaxel Market that help the reader to gain profound knowledge of each and every aspect of the market.